Serum kynurenic acid is reduced in affective psychosis

Keyphrases

• Kynurenic Acid 100%
• Affective Psychosis 100%
• Quinolinic Acid 50%
• Inflammation 33%
• Healthy Controls 33%
• Metabolism 33%
• Psychosis 33%
• Schizophrenia 33%
• Kynurenine Pathway 33%
• D-aspartate 33%
• Psychotic Disorders 33%
• 3-hydroxykynurenine 33%
• Acutely Ill Patients 33%
• Receptor Antagonist 16%
• Receptor Agonist 16%
• Striatal 16%
• Mood Disorders 16%
• Inflammatory Cytokines 16%
• Major Depressive Disorder 16%
• No Significant Difference 16%
• Diagnosis-related Groups 16%
• Affective Disorders 16%
• Bipolar Disorder 16%
• Kynurenine 16%
• Pyramidal Neurons 16%
• Potential Confounders 16%
• Hypofunction 16%
• GABAergic Interneurons 16%
• Neuroactive Steroids 16%
• Disinhibition 16%
• Acid Production 16%
• Non-psychotic Disorders 16%
• Schizoaffective Disorder 16%
• Multiple Testing 16%
• Psychosis Disorders 16%
• Hyperdopaminergia 16%
• Kynurenine 3-monooxygenase 16%
• Kynurenine Metabolites 16%

Neuroscience

• Kynurenic Acid 100%
• Affective Psychosis 100%
• Kynurenine 83%
• Quinolinic Acid 50%
• Metabolic Pathway 33%
• Aspartic Acid 33%
• Psychosis 33%
• 3-Hydroxykynurenine 33%
• Receptor Agonists 16%
• Receptor Antagonist 16%
• Mood Disorder 16%
• Proinflammatory Cytokine 16%
• Interneuron 16%
• Major Depressive Disorder 16%
• Disinhibition 16%
• Bipolar Disorder 16%
• Unspecific Monooxygenase 16%
• Schizoaffective Disorder 16%